140 related articles for article (PubMed ID: 29090456)
41. DNA-Pk
Weaver AN; Cooper TS; Wei S; Carroll WR; Rosenthal EL; Yang ES
Head Neck; 2017 Feb; 39(2):206-214. PubMed ID: 27507640
[TBL] [Abstract][Full Text] [Related]
42. Survival outcome of tonsillar squamous cell carcinoma (TSCC) in the context of human papillomavirus (HPV): A systematic review and meta-analysis.
Ahmadi N; Chan M; Huo YR; Sritharan N; Chin RY
Surgeon; 2019 Feb; 17(1):6-14. PubMed ID: 29843958
[TBL] [Abstract][Full Text] [Related]
43. No evidence of oncogenic KRAS mutations in squamous cell carcinomas of the anogenital tract and head and neck region independent of human papillomavirus and p16(INK4a) status.
Prigge ES; Urban K; Stiegler S; Müller M; Kloor M; Mai S; Ottstadt M; Lohr F; Wenz F; Wagner S; Wittekindt C; Klussmann JP; Hampl M; von Knebel Doeberitz M; Reuschenbach M
Hum Pathol; 2014 Nov; 45(11):2347-54. PubMed ID: 25257576
[TBL] [Abstract][Full Text] [Related]
44. p16 Immunostaining Allows for Accurate Subclassification of Vulvar Squamous Cell Carcinoma Into HPV-Associated and HPV-Independent Cases.
Cheng AS; Karnezis AN; Jordan S; Singh N; McAlpine JN; Gilks CB
Int J Gynecol Pathol; 2016 Jul; 35(4):385-93. PubMed ID: 26630231
[TBL] [Abstract][Full Text] [Related]
45. Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer.
Reimers N; Kasper HU; Weissenborn SJ; Stützer H; Preuss SF; Hoffmann TK; Speel EJ; Dienes HP; Pfister HJ; Guntinas-Lichius O; Klussmann JP
Int J Cancer; 2007 Apr; 120(8):1731-8. PubMed ID: 17236202
[TBL] [Abstract][Full Text] [Related]
46. Biologic importance and prognostic significance of selected clinicopathological parameters in patients with oral and oropharyngeal squamous cell carcinoma, with emphasis on smoking, protein p16(INK4a) expression, and HPV status.
Laco J; Nekvindova J; Novakova V; Celakovsky P; Dolezalova H; Tucek L; Vosmikova H; Vosmik M; Neskudlova T; Cermakova E; Hacova M; Sobande FA; Ryska A
Neoplasma; 2012; 59(4):398-408. PubMed ID: 22489695
[TBL] [Abstract][Full Text] [Related]
47. Basal cell carcinomas of the vulva: high-risk human papillomavirus DNA detection, p16 and BerEP4 expression.
Elwood H; Kim J; Yemelyanova A; Ronnett BM; Taube JM
Am J Surg Pathol; 2014 Apr; 38(4):542-7. PubMed ID: 24625418
[TBL] [Abstract][Full Text] [Related]
48. Role of human papillomavirus in laryngeal squamous cell carcinoma: A meta-analysis of cohort study.
Wang H; Wei J; Wang B; Meng L; Xin Y; Dong L; Jiang X
Cancer Med; 2020 Jan; 9(1):204-214. PubMed ID: 31733044
[TBL] [Abstract][Full Text] [Related]
49. The role of human papillomaviruses in anogenital cancers.
Melbye M; Frisch M
Semin Cancer Biol; 1998 Aug; 8(4):307-13. PubMed ID: 9870037
[TBL] [Abstract][Full Text] [Related]
50. Vulvar Squamous Cell Carcinoma (VSCC) as Two Diseases: HPV Status Identifies Distinct Mutational Profiles Including Oncogenic Fibroblast Growth Factor Receptor 3.
Weberpals JI; Lo B; Duciaume MM; Spaans JN; Clancy AA; Dimitroulakos J; Goss GD; Sekhon HS
Clin Cancer Res; 2017 Aug; 23(15):4501-4510. PubMed ID: 28377483
[No Abstract] [Full Text] [Related]
51. Detection of human papillomavirus in esophageal and gastroesophageal junction tumors: A retrospective study by real-time polymerase chain reaction in an instutional experience from Turkey and review of literature.
Türkay DÖ; Vural Ç; Sayan M; Gürbüz Y
Pathol Res Pract; 2016 Feb; 212(2):77-82. PubMed ID: 26608416
[TBL] [Abstract][Full Text] [Related]
52. Genetic imbalance and human papillomavirus states in vulvar squamous cell carcinomas.
Yangling O; Shulang Z; Rongli C; Bo L; Lili C; Xin W
Eur J Gynaecol Oncol; 2007; 28(6):442-6. PubMed ID: 18179133
[TBL] [Abstract][Full Text] [Related]
53. Population-based evidence of increased survival in human papillomavirus-related head and neck cancer.
Nygård M; Aagnes B; Bray F; Møller B; Mork J
Eur J Cancer; 2012 Jun; 48(9):1341-6. PubMed ID: 22516210
[TBL] [Abstract][Full Text] [Related]
54. Keratinizing-type squamous cell carcinoma of the oropharynx: p16 overexpression is associated with positive high-risk HPV status and improved survival.
Cai C; Chernock RD; Pittman ME; El-Mofty SK; Thorstad WL; Lewis JS
Am J Surg Pathol; 2014 Jun; 38(6):809-15. PubMed ID: 24698966
[TBL] [Abstract][Full Text] [Related]
55. The association of pre-treatment HPV subtypes with recurrence of VIN.
Bogani G; Martinelli F; Ditto A; Signorelli M; Taverna F; Lombardo C; Chiappa V; Leone Roberti Maggiore U; Recalcati D; Scaffa C; Perotto S; Sabatucci I; Indini A; Lorusso D; Raspagliesi F
Eur J Obstet Gynecol Reprod Biol; 2017 Apr; 211():37-41. PubMed ID: 28178576
[TBL] [Abstract][Full Text] [Related]
56. Prevalence of Human Papillomavirus in endometrial cancer: a systematic review and meta-analysis.
Olesen TB; Svahn MF; Faber MT; Duun-Henriksen AK; Junge J; Norrild B; Kjaer SK
Gynecol Oncol; 2014 Jul; 134(1):206-15. PubMed ID: 24607284
[TBL] [Abstract][Full Text] [Related]
57. Is human papillomavirus and p16 expression associated with survival outcomes in nasopharyngeal cancer?: A systematic review and meta-analysis.
Tham T; Teegala S; Bardash Y; Herman SW; Costantino P
Am J Otolaryngol; 2018; 39(6):764-770. PubMed ID: 30029797
[TBL] [Abstract][Full Text] [Related]
58. Genetic aberrations detected by comparative genomic hybridisation in vulvar cancers.
Allen DG; Hutchins AM; Hammet F; White DJ; Scurry JP; Tabrizi SN; Garland SM; Armes JE
Br J Cancer; 2002 Mar; 86(6):924-8. PubMed ID: 11953825
[TBL] [Abstract][Full Text] [Related]
59. [Update regarding the management of vulvar cancer: The guidelines of the Assistance Publique-Hôpitaux de Paris].
Azaïs H; Pauphilet V; Belghiti J; Nikpayam M; Gonthier C; Maingon P; Conforti R; Uzan C; Canlorbe G;
Bull Cancer; 2019 Apr; 106(4):371-378. PubMed ID: 30898319
[TBL] [Abstract][Full Text] [Related]
60. Epidemiology of vulvar neoplasia in the NIH-AARP Study.
Brinton LA; Thistle JE; Liao LM; Trabert B
Gynecol Oncol; 2017 May; 145(2):298-304. PubMed ID: 28236455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
